Leadership Overview
Tolmar has 6 executives leading key functions including strategy, finance, medical affairs, operations, legal, and commercialization.
Driven by innovation, Tolmar is dedicated to the development, manufacturing, and commercialization of specialty pharmaceuticals, impacting multiple therapeutic areas with a strong focus on Urology.
Driven by innovation, Tolmar is dedicated to the development, manufacturing, and commercialization of specialty pharmaceuticals, impacting multiple therapeutic areas with a strong focus on Urology.
Leadership Roles at Tolmar
Anil D'Souza - Chief Executive Officer
Anil D'Souza, the Chief Executive Officer at Tolmar, directs the company's overall strategy and operational execution. D'Souza guides the integrated approach to pharmaceutical development, manufacturing, and commercialization across diverse therapeutic areas, with a specific emphasis on Urology. This leadership role involves fostering innovation and ensuring the successful market introduction of specialty pharmaceuticals. Overseeing global operations from Northern Colorado, D'Souza ensures alignment with the company's mission. Anil D'Souza drives the long-term vision for Tolmar, focusing on sustainable growth and expanding market reach through strategic initiatives. The Chief Executive Officer's purview encompasses all facets of the business, from research and development to market access and patient care.
Jeff Lederman - Chief Financial Officer
Jeff Lederman, the Chief Financial Officer at Tolmar, manages all financial operations and strategic financial planning. Lederman oversees budgeting, forecasting, and capital allocation to support the company's innovative development, manufacturing, and commercialization efforts in specialty pharmaceuticals. This executive ensures robust financial health and drives fiscal responsibility across all departments, including those focused on Urology. From the Northern Colorado headquarters, Lederman provides critical financial insights to guide business decisions and investment strategies. Jeff Lederman's leadership is essential for maintaining financial stability and enabling the expansion of Tolmar's product portfolio. The Chief Financial Officer's responsibilities include managing investor relations and optimizing financial performance to support long-term company objectives.
Shawn Silvestri - President & Chief Operating Officer
Shawn Silvestri, the President & Chief Operating Officer at Tolmar, orchestrates the company's day-to-day operations and drives operational excellence. Silvestri manages the intricate processes of product development, manufacturing, and supply chain logistics, ensuring efficiency and quality across all facilities, including those in Northern Colorado. This executive's focus is on optimizing internal workflows to support the commercialization of specialty pharmaceuticals. Overseeing the seamless execution of Tolmar's business model, Silvestri ensures that operational capabilities align with strategic goals. Shawn Silvestri's leadership is critical for scaling production and maintaining the high standards required in the pharmaceutical industry. The President & Chief Operating Officer's responsibilities extend to ensuring regulatory compliance and driving continuous improvement in manufacturing processes.
Steve Griffin - President, North America
Steve Griffin, the President, North America at Tolmar, leads the commercial strategy and execution across the United States and Canada. Griffin directs sales, marketing, and market access initiatives, driving the commercialization of specialty pharmaceuticals within the region, with a significant focus on Urology. This executive ensures Tolmar's products reach patients and healthcare providers effectively, leveraging insights from the North America commercial headquarters in Buffalo Grove, Illinois. Overseeing regional operations, Griffin fosters strong relationships with key stakeholders and partners. Steve Griffin's leadership is instrumental in achieving regional sales targets and expanding market share. The President, North America's role involves adapting global strategies to meet the specific demands and opportunities within the North American market.
Anjan Chatterjee - Chief Medical Officer & Chief Marketing Officer
Anjan Chatterjee, the Chief Medical Officer & Chief Marketing Officer at Tolmar, spearheads both clinical strategy and market engagement. Chatterjee directs the medical affairs division, ensuring the scientific integrity and efficacy of specialty pharmaceuticals, particularly within Urology. Concurrently, this leader shapes and executes comprehensive marketing strategies to drive product adoption and market penetration. Overseeing the integration of medical insights with commercial objectives, Chatterjee ensures Tolmar's offerings meet critical patient and physician needs. Anjan Chatterjee's dual role is pivotal in translating complex medical advancements into accessible, impactful commercial solutions. The Chief Medical Officer & Chief Marketing Officer's leadership bridges scientific innovation with market demand, fostering growth across all therapeutic areas.
Michael Elm - Chief Legal Officer
Michael Elm, the Chief Legal Officer at Tolmar, provides strategic legal counsel and oversees all legal affairs for the company. Elm manages corporate governance, intellectual property, regulatory compliance, and litigation, ensuring Tolmar operates within all legal frameworks. This leadership role is crucial for protecting the company's assets and interests during the development, manufacturing, and commercialization of specialty pharmaceuticals. From the Northern Colorado base, Elm advises on legal implications across all business functions, including those related to Urology. Michael Elm's expertise is vital for navigating the complex regulatory landscape of the pharmaceutical industry. The Chief Legal Officer's responsibilities include mitigating legal risks and supporting the company's strategic objectives through sound legal guidance.
Explore Leadership Teams in Manufacturing
Founded in 1947 and headquartered in Mumbai, Indoco Remedies Limited is a fully integrated, research-oriented pharma company. Indoco specializes in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs).
Company Leadership
AR
AK
BD
Founded in 1850 and headquartered in Johannesburg, South Africa, Aspen Pharmacare Holdings Limited is a global specialty and branded pharmaceutical company headquartered in Durban, South Africa. Operating across Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia, Aspen focuses on sterile injectables (including anaesthetics, anticoagulants, antithrombotics, analgesics, and hormone replacement therapies), over-the-counter medicines, and prescription products for conditions such as hypothyroidism, autoimmune disease, pain, gout, and inflammatory disorders. The company also manufactures active pharmaceutical ingredients and finished dose forms, including steriles, oral solids, liquids, semi-solids, biologicals, and heparins, supplying both its own brands and third-party customers worldwide.
Company Leadership
TS
RM
SC
UCB is a global biopharmaceutical company headquartered in Brussels, Belgium, founded in 1928. The company specializes in the discovery, development, and commercialization of innovative medicines for people living with severe neurological and autoimmune conditions. UCB's core therapeutic focus spans neurology — including epilepsy and Parkinson's disease — and immunology, encompassing conditions such as rheumatoid arthritis, Crohn's disease, psoriasis, and axial spondyloarthritis. Its marketed product portfolio includes Cimzia, Vimpat, Keppra, Briviact, Neupro, Bimzelx, Evenity, and Fintepla, among others. The company operates in more than 40 countries, with its U.S. headquarters located in Smyrna, Georgia, and additional sites across the United States supporting clinical development, research, and policy functions. UCB integrates patient and caregiver insights directly into its research and development process, combining scientific innovation with a commitment to health equity and sustainable value creation.
Company Leadership MD
DX
CD
SO
Founded in 1891, Adcock Ingram is a pharmaceutical manufacturer headquartered in Gauteng, South Africa. Adcock Ingram manufactures, markets and distributes a range of healthcare products.
Company Leadership AH
WR
FC
GH
Frequently Asked Questions Regarding Tolmar Top Executives and Leadership Team
Unlock more people and company data
